Zota Health Care acquires 80% stake in Globotask IT Consultancy for Rs 25 lakh

What Zota Health Care announced

Zota Health Care Limited (NSE: ZOTA) informed the National Stock Exchange on 22 June 2026 that its board had approved the acquisition of an 80% stake in Globotask IT Consultancy Services Private Limited (GITCPL). The deal involved the purchase of 8,000 equity shares of GITCPL for a cash consideration of Rs 25 lakh. Upon completion, GITCPL will become a subsidiary of Zota, enabling the listed company to offer a broader suite of information‑technology services.

"The Company has made investment in GITCPL to provide IT solutions, including cloud‑based software development, Android/iOS application, website development and customized ERP software to the Company and its subsidiaries."

Details of the target entity

GITCPL is an Indian private limited company incorporated on 4 November 2022. It operates in the Information Technology sector, delivering services such as:

• Custom software development and made‑to‑order software
• Web‑page designing, web hosting and cloud‑based solutions
• Application support, maintenance and disaster recovery
• Development of Android and iOS mobile applications
• Tailored ERP systems for enterprise clients

Financially, the audited statements for FY 2025‑26 show a turnover of Rs 19.28 lakh and a paid‑up share capital of Rs 1 lakh. The turnover for the two preceding years was Rs 8.14 lakh (FY 2024‑25) and Rs 13.06 lakh (FY 2023‑24), indicating modest growth in the nascent business.

Transaction terms and structure

The acquisition was executed on a cash‑only basis. Zota paid Rs 25 lakh to acquire 8,000 equity shares, representing 80% of the share capital of GITCPL. The remaining 20% of shares continue to be held by the existing promoters, who have no interest in Zota and are not part of the promoter group of the listed entity. The filing explicitly states that the transaction does not fall within the ambit of related‑party transactions and was carried out on an arm‑length basis.

No governmental or regulatory approvals were required for the deal, as confirmed in Annexure‑I of the filing. The acquisition was completed on the same day the intimation was sent to the exchange – 22 June 2026 – and the target will now be accounted for as a subsidiary in Zota’s consolidated financial statements.

Key facts at a glance

Why this matters for investors

The acquisition adds a dedicated IT services platform to Zota’s existing health‑care operations. By bringing GITCPL under its umbrella, Zota can internally develop and maintain software applications, cloud solutions and ERP systems that support its own business units and potentially generate third‑party revenue. Because the purchase was funded entirely with cash, there is no immediate dilution of existing shareholders’ equity.

The modest size of GITCPL (turnover under Rs 20 lakh) suggests that the deal is strategic rather than financial; Zota appears to be building capabilities that could improve operational efficiency and open new service‑based revenue streams. The absence of related‑party concerns and regulatory hurdles reduces execution risk, and the swift completion indicates that the board had a clear mandate.

Investors should note that the subsidiary will be reflected in future consolidated statements, and any profitability or cash‑flow contribution from GITCPL will depend on how effectively Zota integrates the IT services into its broader business model.

Conclusion

Zota Health Care Limited has completed the acquisition of an 80% stake in Globotask IT Consultancy Services Private Limited for Rs 25 lakh, making the IT firm a subsidiary. The transaction is cash‑based, arm‑length and free of related‑party issues, with no regulatory approvals required. While the target’s current turnover is modest, the move expands Zota’s technological capabilities and may support future diversification, subject to successful integration and execution.